These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29325993)

  • 1. Serum haptoglobin in Chinese patients with Alzheimer's disease and mild cognitive impairment: A case-control study.
    Zhu CJ; Jiang GX; Chen JM; Zhou ZM; Cheng Q
    Brain Res Bull; 2018 Mar; 137():301-305. PubMed ID: 29325993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Shekhar S; Kumar R; Rai N; Kumar V; Singh K; Upadhyay AD; Tripathi M; Dwivedi S; Dey AB; Dey S
    PLoS One; 2016; 11(7):e0159099. PubMed ID: 27459603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Homocysteine and Serum Folate and Vitamin B
    Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
    Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
    J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
    Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
    Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
    Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
    Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.
    Lu R; Wang J; Tao R; Wang J; Zhu T; Guo W; Sun Y; Li H; Gao Y; Zhang W; Fowler CJ; Li Q; Chen S; Wu Z; Masters CL; Zhong C; Jing N; Wang Y; Wang Y
    Mol Psychiatry; 2018 Mar; 23(3):767-776. PubMed ID: 28696436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.
    Wang X; Zimmermann HR; Lockhart SN; Craft S; Ma T
    J Alzheimers Dis; 2020; 76(1):217-224. PubMed ID: 32444538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of AD7C-NTP for patients with mild cognitive impairment due to Alzheimer's disease].
    Chen Y; Shi S; Zhang J; Gao H; Liu H; Wang J; Lin H
    Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(21):1613-7. PubMed ID: 25152281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPC6 mRNA levels in peripheral leucocytes of patients with Alzheimer's disease and mild cognitive impairment: A case-control study.
    Chen JM; Li QW; Liu JS; Jiang GX; Liu JR; Chen SD; Cheng Q
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():279-284. PubMed ID: 30684527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
    Mandal PK; Saharan S; Tripathi M; Murari G
    Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
    Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
    J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.